Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Q2W Darbepoetin Alfa in Chronic Renal Insufficiency
NCT00526929Phase 2Completed
- Sponsor
- Amgen
- Start
- May 2000
- Primary completion
- Feb 2002
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started May 2000; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00526929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526929.